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Abstract
Thiol peroxidase, Tpx, has been shown to be a target protein of the salicylidene acylhydrazide class of antivirulence
compounds. In this study we present the crystal structures of Tpx from Y. pseudotuberculosis (ypTpx) in the oxidised and
reduced states, together with the structure of the C61S mutant. The structures solved are consistent with previously solved
atypical 2-Cys thiol peroxidases, including that for ‘‘forced’’ reduced states using the C61S mutant. In addition, by
investigating the solution structure of ypTpx using small angle X-ray scattering (SAXS), we have confirmed that reduced
state ypTpx in solution is a homodimer. The solution structure also reveals flexibility around the dimer interface. Notably, the
conformational changes observed between the redox states at the catalytic triad and at the dimer interface have
implications for substrate and inhibitor binding. The structural data were used to model the binding of two salicylidene
acylhydrazide compounds to the oxidised structure of ypTpx. Overall, the study provides insights into the binding of the
salicylidene acylhydrazides to ypTpx, aiding our long-term strategy to understand the mode of action of this class of
compounds.
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Introduction
Thiol peroxidase (Tpx, p20, scavengase) is an atypical 2-Cys
peroxiredoxin present throughout the eubacteria, including
pathogenic strains, such as Escherichia coli O157:H7 [1], Yersinia
sp., Haemophilus influenzae, Streptococcus pneumoniae and Helicobacter
pylori [2]. Tpx constitutes part of the bacterial defence system
against reactive oxygen species (ROS) and, correspondingly, is
upregulated when E. coli is exposed to oxidative stress [1]. Tpx
functionality specifically relies on the reducing equivalents from
thioredoxin (Trx1) and thioredoxin reductase (TrxR) [3]. The
catalytic cycle of peroxiredoxin activity consists of three steps; 1)
peroxidation, 2) resolution and 3) recycling [4]. Atypical 2-Cys
peroxiredoxins are functionally monomeric, in contrast to the
typical peroxiredoxins, i.e. the resolving (Cr) and the peroxidasic
(Cp) cysteines (C61 and C95, respectively in the case of Tpx) are
situated on the same subunit. Structurally, this involves the
reduced Tpx encountering a ROS, such as hydrogen peroxide or
an alkyl hydroperoxide, and the covalent binding of O
2 to Cp.
The ROS is released as H2O resulting in the formation of a
disulphide bridge between Cp and Cr. The cycle is completed by a
transient interaction with Trx1, ending with two separate cysteine
side-chains on Tpx (Figure 1).
Tpx contains three cysteine residues, two of which (C61and
C95) form the redox active disulphide bond. The third cysteine
(C82) is not involved in the redox activities of Tpx [3], and is not
involved in any covalent interactions. Until now, twelve structures
of Tpx have been elucidated, from E. coli [4,5], Bacillus subtilis [6],
Aquifex aeolicus, Mycobacterium tuberculosis [7,8], H. influenzae, and S.
pneumoniae. Most of these structures have been solved in the
oxidised state, or in the ‘‘forced’’ reduced state of the C61S (or
equivalent) mutant. Two wild-type reduced structures have been
solved, one by NMR [6] and one by X-ray crystallography
(Structural Genomics Consortium).
Initially presumed to be localised in the periplasm [1], recent
work using cross-linking and fractionation studies [9] has shown
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32217that Tpx is one of several peroxiredoxins in the cytosol of E. coli.
Tpx has been shown to be important for the survival of S.
typhimurium in macrophages, where the oxidative burst can be
particularly acute [10].
We have recently shown that Tpx is one of several proteins
bound by a class of ‘‘anti-virulence’’ compounds, the salicylidene
acylhydrazides [11]. These compounds are broadly effective in
reducing the expression of the type three secretion system (T3SS)
of a range of Gram-negative pathogens including Chlamydia spp.,
Salmonella enterica serovar Typhimurium, Yersinia pseudotuberculosis,
Shigella flexneri, and E. coli O157 [12]. The T3SS is a critical
determinant used by pathogens to modulate host cell processes
and facilitate processes such as binding and invasion [13] so
compounds that interfere with its expression or function have the
potential to become novel anti-infective agents [12,14].
The precise molecular mechanism of action of the salicylidene
acylhydrazides is not fully understood, although our identification
of multiple binding proteins suggests a synergistic effect arising
from a modulation of the activity of several proteins, including
Tpx. The binding affinity of the salicylidene acylhydrazide
compound ME0052 [N9-(3,5-dibromo-2-hydroxy-benzylidene)-
nicotinic acid hydrazide] to Tpx from Y. pseudotuberculosis (ypTpx)
was measured using analytical ultracentrifugation (AUC) and
showed that a catalytically inactive mutant of Tpx displayed a two-
fold reduction in binding [11]. In this mutant, cysteine 61 was
specifically mutated to a serine residue (C61S). The C61S mutant
Tpx is present only in its reduced form and cannot undergo the
intramolecular disulphide bond formation critical for the catalytic
cycle of the protein.
In the current study, we present the crystal structures of ypTpx
in the oxidised and reduced states together with the structure of
the C61S mutant. These structural data, combined with our
previous NMR chemical shift analysis, allow us to perform
detailed molecular modelling of how the salicylidene acylhydra-
zides bind to target proteins. This work helps our understanding of
the mode-of-action of this class of anti-virulence compounds.
Results and Discussion
Purified Tpx is active and bound by the salicylidene
acylhydrazides
Tpx can be readily purified using nickel affinity chromatogra-
phy, thereby facilitating structural and subsequent biochemical
studies. The activity of purified ypTpx was tested using a glutamine
synthetase (GS) assay, where an active peroxiredoxin protects
against ROS [15]. Two micrograms of ypTpx rescued 50% of
initial GS activity, with 15 mgo fypTpx raising GS activity to 90%
of initial activity, clearly demonstrating that ypTpx was indeed
active and reduced H2O2 (Figure 2). Previous characterisation of
Tpx from E. coli (ecTpx) has shown a substrate specificity for alkyl
hydroperoxides over H2O2, with a Km of 9 mM for cumene
peroxide compared with a Km.1.7 mM for H2O2 [3]. However,
despite this lower substrate specificity, analysis of mutants in
Salmonella revealed that a Tpx mutant was highly susceptible to
exogenous H2O2 [10].
Crystal structures
To determine the high-resolution structure of Tpx, recombinant
ypTpx in reduced and oxidised state, and the mutants ypTpxC61S
were crystallised. ypTpx crystallised in three crystal forms, 1, 2 and
3, in three different space groups, P21, P64 and P212121,
respectively, as described elsewhere [16]. Crystal forms 1 and 2
grew in conditions containing DTT, and the solved structures
were in the reduced state. Crystal form 1 diffracted to 2.00 A ˚, and
the structure comprised three dimers in the asymmetric unit. The
six chains superpose well, with root-mean-square-deviations
(r.m.s.d.) of less than 0.5 A ˚. Crystal form 2, diffracting to
2.35 A ˚, comprises a single subunit in the asymmetric unit, the
complete dimer being made up by symmetry operators.
As there are only minor differences between the two reduced
structures, with an r.m.s.d. of 0.4 A ˚ over 160 Ca, only the highest
resolution structure (space group P21) will be discussed here. Most
residues are accounted for in the electron density, apart from the
hexa-histidine tag. The reduced structure refined to Rwork- and
Rfree -factors of 22.2% and 26.8%, respectively. Refinement
statistics for all structures are presented in Table 1.
ypTpx has a regular thioredoxin-like fold: a seven-stranded b-
sheet, with b2 and b6 running anti-parallel to the rest, although
with an inserted N-terminal b-hairpin (bN1-bN2) (Figure 3) absent
Figure 1. Redox cycle of Tpx. The reduction of ROS by oxidation
(step 1) of Tpx producing H2O (step 2). The oxidised form (disulphide
bond) of Tpx is recovered by thioredoxin (Trx), and returned to the
reduced form (step 3).
doi:10.1371/journal.pone.0032217.g001
Figure 2. Glutamine synthetase assay. The activity of ypTpx is
confirmed by its ability to rescue the activity of glutamine syntethase
(to 90% of original activity at 15 mg ypTpx).
doi:10.1371/journal.pone.0032217.g002
Tpx from Yersinia pseudotuberculosis
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helices following b3, b4, b5 and b7, and one short 310 helix
following b2. The numbering of the b-strands is based upon that of
ecTpx [5] to make direct comparisons between all Tpx molecules
easier. bN1-bN2 (Figure 3) forms an L-shaped hydrophobic cleft,
and it has been speculated that this cleft allows Tpx to
accommodate the long fatty acid hydroperoxides [17].
Crystal form 3 captured ypTpx in the oxidised state with an
intact intramolecular disulphide bond between Cys61 and Cys95.
The crystal belonged to space group P212121 and diffracted to
1.74 A ˚. The overall oxidised structure, diffracting to a resolution
of 1.74 A ˚ and presenting space group P212121, is similar to that of
the reduced structure, except for some differences that are mostly
confined to the region around the active site (see below).
As part of this study, the structure of ypTpxC61S was solved to a
resolution of 2.55 A ˚ in space group P64. This structure represents
the ‘‘forced’’ reduced form of the protein, as the resolving cysteine
has been mutated to a serine, rendering it catalytically inactive [3].
All of our solution data indicate that the mutant structure and the
reduced wild type structure are identical, and that the oligomeric
statesarethe same.When superimposedonto thereduced structure,
the r.m.s.d. was 0.52 A ˚ over 163 Ca (Figure S1). This fits well with
the structural analysis of Hall et al. [4] who used the TpxC61S
mutant from E. coli to describe the structure of reduced Tpx.
ypTpx crystallised either as a dimer in the asymmetric unit,
where the two subunits superposed with an r.m.s.d. of less than
0.2 A ˚, or the dimer could be created by crystallographic symmetry
operators. The dimer interface comprises about 20 residues from
each subunit, corresponding to 12% of total surface residues,
according to the PISA server [18]. The interfaces are formed
mostly by hydrophobic interactions, with a few hydrogen bonds,
namely between R110NH1 and three main-chain carboxyl groups
on the opposing subunit (G125, P126, A128). There are no salt
bridges or covalent bonds between the two dimers in the reduced
structure. The dimer interfaces are identical in the structures of
reduced Tpx and C61S.
The dimer interface is of similar size in the oxidised state but in
addition to the hydrogen bond pattern described above, there are
also salt bridges formed between D57 and R93 on opposing
subunits (Figure 3C). This is due to the conformational change
between the reduced and oxidised states.
Active site
The redox active site of Tpx is made up by CP and CR (C61 and
C95 in ypTpx, respectively). There is a conformational change
between the two states, involving the partial unfolding of helices a1
and a2, and a shift of 8.4 A ˚ for C61 and 5.1 A ˚ for C95,
respectively, as presented in Figure 4. The two structures
superpose well, in particular the core parts, with an r.m.s.d of
0.7 A ˚ over 135 Ca. Inclusion of the unfolding helices increases the
r.m.s.d. to 1.02 A ˚.
The partial unfolding of a1 opens a cleft in Tpx formed between
the loops connecting b1 and a1, a3 and b6, and b7 and a5o n
subunit A and connecting b1 and b2, and b4 and a2 on subunit B.
When in the reduced state, C61 is orientated into the pocket where
it is available for oxidation by H2O2 or alkyl peroxides. This cleft
makes up the active site of Tpx, and has been described in detail
by Hall et al. [4]. In this manuscript they present the fully intact
peroxide binding site (a reduced C61S mutant), the locally
unfolded binding site (oxidised), and a partially unfolded
transitional state (seen only for the double C82, 95S mutant) for
Tpx from E. coli that shares an identical active site.
Oligomeric state
Peroxiredoxins exhibit a wide variety of oligomeric states,
ranging from monomeric (YPrx, [19]), to large decameric or
dodecameric assemblies like TryP [20], AhpC [21] and other
typical 2-Cys peroxiredoxins, including PrxIII from bovine
mitochondria, which forms two concatenated dodecamers [22].
These assemblies are often dependent on redox state, dissociating
into homodimers upon oxidation [23]. Previous studies of ecTpx
showed that the protein is a homodimer, regardless of the redox
state, and despite the lack of any inter-subunit disulphide bond [3].
We analysed the oligomeric state of oxidised and reduced ypTpx,
as well as the C61S mutant by AUC and SAXS. Sedimentation
velocity (SV) experiments revealed that all three forms of ypTpx
were completely monodisperse in solution, as evidenced by a single
dominant peak in the c(s) distribution (Figure 5). Infinite dilution
sedimentation coefficients (S
0
20,w) were determined from the
concentration dependence of s20,w (obtained from fitting the SV
data with a non-interacting discrete species model in SEDFIT
[24]) for the oxidised and reduced forms of ypTpx (S
0
20,w =3.04
Table 1. Refinement statistics for reported structures.
Reduced Tpx Reduced Tpx Oxidised Tpx Tpx C61S
PDB code 2XPD 3ZRE 3ZRD 2YJH
Space group P21 P64 P212121 P64
Unit cell (A ˚) a=64.86
b=92.07
c=85.60
b=91.41u
a=65.01
c=86.28
a=56.18
b=62.56
c=88.00
a=65.03
c=85.60
Resolution (A ˚) 44.67 – 2.00 56.30 - 2.35 28.09 - 1.74 56.32 - 2.55
Protein residues (atoms) 903 (7449) 165 (1191) 339 (2517) 164 (1188)
Water molecules 490 12 199 4
Ligands DTT N/A N/A N/A
Rwork (%) 22.5 23.5 19.5 31.3
Rfree (%) 26.8 27.3 23.13 33.6
R.m.s.d. for bond lengths (A ˚)/angles (u) 0.022/1.8 0.02/1.995 0.009/1.080 0.005/0.772
Ramachandran allowed regions (%) 99.8 97.6 100.0 97.6
doi:10.1371/journal.pone.0032217.t001
Tpx from Yersinia pseudotuberculosis
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32217Figure 3. Crystal structures. (A) Cartoon representation of oxidised ypTpx. Strands and loops are purple, helices are green, and the disulphide
bond is represented as sticks. The N-terminal hairpin is highlighted in pink. The secondary structure elements are labelled. (B) Sequence alignment of
Tpx from a number of pathogens, with the secondary structure based on ypTpx. Black represents identical, and red highly similar residues (based on
Tpx from Yersinia pseudotuberculosis
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0
20,w is 2.80 S,
suggesting that this mutation does not induce structural instability
(i.e. the value is comparable with those determined for reduced
and oxidised ypTpx).
Sedimentation equilibrium (SE) data were fitted with the species
analysis model in SEDPHAT [25]. From the concentration
dependence of the resultant apparent mass of the single species
the infinite dilution mass (M
0) was determined to be 41.563.4,
38.462.9, 39.460.4 kDa for oxidised, reduced and C61S ypTpx
respectively. The mass of ypTpx dimer, including the tag,
calculated from its amino acid sequence is 42,382 Da, which is
consistent with the experimentally determined masses. This
indicates that ypTpx is present solely as a dimer in solution. It
was not possible to fit the SE data with a monomer-dimer (or any
other plausible) self-association model, which is further consistent
with the complete dimerisation of the protein in the concentration
range studied.
Solution structure
The solution structures of ypTpx and the C61S mutant were
investigated using SAXS, a powerful method to structurally
analyse proteins in solution under more physiologically relevant
conditions [26]. Figure 6A shows a SAXS curve for ypTpxC61S,
representative of the data obtained for ypTpx in both oxidising and
reducing conditions. ypTpxC61S was obtained at a higher
concentration than the other samples, and subsequently produced
better scattering data. The Dmax and Rg of ypTpx and ypTpxC61S,
obtained by indirect Fourier transform with GNOM [27], were
the same (70.5 A ˚ and 24.060.2 A ˚, respectively) indicative that
conformational changes induced by disulphide bond formation are
too small to be detected by SAXS. Theoretical scattering curves of
monomeric and dimeric atomic structures of Tpx were calculated,
and again confirm that Tpx is a dimer in solution (Figure 6A). A
low-resolution (11 A ˚) envelope of ypTpxC61S (Figure 6B) in
solution was generated using the ab initio modelling program
DAMMIN [28]. The fit of the model to the data is shown in
Figure 6A.
The high-resolution structure superimposes well onto the low-
resolution envelope (Figure 6B). The Dmax of the space-fill model
of the dimer crystal structure is approximately 68 A ˚, which agrees
with the Dmax obtained from the SAXS data (70.5 A ˚), indicating
that the low-resolution envelope describes the ypTpx dimer. The
differences in the Dmax values obtained from the two methods are
small, and may be explained by the fact that in the crystal
structure there is no electron density to account for the two N-
terminal residues of Tpx plus the hexa-histidine tag, therefore it
has not been included in calculations. However, as these residues
were present in the ypTpx studied by SAXS, we would expect the
Dmax value observed in solution by SAXS to exceed that
calculated for the incomplete crystal structure.
Rigid body modelling of the oxidised Tpx crystal structure
against the SAXS data, using BUNCH [29], based on a single
chain, and imposing P2 symmetry yielded a model similar to that
for the dimeric crystal structure. Comparison of the crystallo-
graphic model with the one fitted to the solution data using
DYNDOM [30] yielded a rotation angle of 21.4u and a 5 A ˚
translation. This freedom of movement corresponds well with that
observed for the structures of Tpx from other different species [4].
Modelling of salicylidene acylhydrazide compounds to
ypTpx
We have previously used NMR chemical shift mapping to
identify ypTpx amide groups that were shifted upon addition of
200 mM ME0052. The study mapped these shifting residues onto
the published TpxC61S structure from E. coli (PDB code 3HVV)
to show they clustered to a defined region of the protein. Now we
have obtained the high-resolution structure of ypTpx itself,
allowing us to model the binding of ME0052 and ME0055 to
both the oxidised and reduced forms of the protein and examine
how this correlates with the NMR data. These two compounds
were docked into the receptor structures using MOE Dock, and
the 25 best poses determined for each compound were ranked
after energy minimisation and dock scoring. Figure 7 shows the
lowest energy binding modes for ME0052 (Figure 7A) bound to
oxidised ypTpx. Docking using ME0055 gave equivalent binding
poses (data not shown). The binding pocket is mostly hydrophobic
(Figure 7A) with one hydrogen bond proposed between the
ME0052 p-hydroxyl to the ypTpx I153 carbonyl, which fits with
the chemical shift change for the neighbouring T154 amide
(Figure 7B). The chemical shift data indicated significant shifts in
the amides of residues from both subunits, highlighting the
importance of the dimer interface for the generation of the binding
pocket and compound binding, as illustrated in Figure S2A. The
binding site is also consistent with previously published Tpx-
substrate models [32].
Figure 4. Comparison of the oxidised and reduced active site. (A) Close-up of the active cysteines in the reduced structure. C61 is shown to
occlude the active site cleft. (B) Close-up of the reduced structure. The formation of the disulphide bond shifts the helix and opens a cleft, which
allows substrate access.
doi:10.1371/journal.pone.0032217.g004
an ALSCRIPT algorithm level of 0.7 [53]). The unravelling regions of a1 and a2, caused by the change of redox state, are highlighted by the lighter
colour in the secondary structure elements. The reactive C residues are highlighted in yellow, and C61S is marked by a triangle. (C) Close-up of the
dimer interface with the residues involved interactions marked as sticks, and salt bridges and hydrogen bonding partners are labelled. Bonds are
shown in dashes.
doi:10.1371/journal.pone.0032217.g003
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to C61 folds into the binding pocket predicted to accommodate the
compound.Similarly, the side chain ofR133 undergoesa significant
conformational change. Collectively, these conformational changes
reduce the overall volume of the binding pocket (Figure 7C) and are
predicted to affect the binding of ME0052 to the reduced state of
ypTpx by inducing steric clashes. In fact, MOE Dock as not able to
find a suitable docking pose for the reduced state of ypTpx,
presumably because the binding site is occluded by the folded
extension of the a1 helix in the reduced state.
Accurately measuring the binding of the salicylidene acylhy-
drazides to any protein has proved problematic due to the low
solubility of the compounds in physiologically relevant solvents.
This has prohibited the application of techniques including
isothermal calorimetery and surface plasmon resonance that
would be default methods to measure binding of ligands to
proteins. Previously we have used an AUC-based method to
estimate Kd, giving values of 51 and 71 mM for the binding of
ME0052 to oxidised and reduced ypTpx, respectively [11]. These
data suggest only minor differences in compound binding to ypTpx
in the two oxidation states, although we would exercise caution in
the interpretation of these data due to the inherent inaccuracy of
measuring Kd by this method.
An alternative binding pose, that would accommodate binding of
ME0052 or ME0055, to both the oxidised and reduced forms of
ypTpx is presented as Figure S2B Although this model would require
some conformational accommodation of the binding site, the
compounds are predicted to be less buried in the pocket and
therefore binding would be largely equivalent irrespective of the
oxidation state of Tpx. Such conformational accommodation is
plausiblegiven the large backbone fluctuations observed in each state.
Far-western analysis
To test the binding of ypTpx to salicylidene acylhydrazide
compounds, far-western blotting was used in which the protein
was resolved by SDS-PAGE, transferred to a nitrocellulose
membrane and probed using biotinylated ME0052 (ME0052-
bio) [33,34]. Interactions were then detected using a StreptAvidin-
HRP conjugate in a process similar to that used for a routine
western blot. Following SDS-PAGE and staining by Coomassie
blue, Tpx could be seen as a monomer of 21 kDa as well as a
dimer of 42 kDa (Figure 8). In comparison, the purified C61S
mutant was present only as a monomer of 21 kDa. This difference
can be attributed to the changes in the strength of the dimer
interface, arising from the loss of two salt bridges in the ‘forced’
reduced C61S mutant, which in turn is more susceptible to the
heat and detergent experienced during the far-western blotting
procedure. Far-western analysis indicated that ME0052-bio binds
with a far higher affinity to ypTpx dimer, as over four times the
amount of signal was seen corresponding to the dimer compared
with the monomer (see Material and Methods). This finding is
particularly stark when the relative proportions of dimer and
monomer indicated on the gel are considered: quantification of the
monomer-dimer on the SDS-PAGE gel indicated the ratio of these
two species was 15:1. This finding confirmed our previous data
[11] showing binding of ME0052-bio when tested against E. coli
overexpressing ecTpx but is more unambiguous as it demonstrates
binding to purified protein rather than through probing crude
lysates. The caveat with this approach is that the protein must
refold before binding the ligand. It could be that the better binding
of the ligand to the dimer is simply due to an inherently more
stable dimeric structure compared with the dissociated monomer.
Figure 6. SAXS results. (A) The experimental scattering curve of
ypTpxC61S (grey), overlaid with the curves for monomeric Tpx (green)
and dimeric Tpx (purple) (calculated using CRYSOL [50]) confirming the
dimeric solution state of the protein. The fit of the ab initio model to the
experimental data is shown in red. Inset is the distance distribution
function (p(r) versus r) of ypTpxC61S with error bars. (B) Space-filled
crystal structure of ypTpxC61S (purple) superposed onto the averaged
DAMMIN ab initio model (grey) using the program SUPCOMB [49].
doi:10.1371/journal.pone.0032217.g006
Figure 5. Analytical ultracentrifugation. c(s) distributions derived
via SEDFIT from SV data for ypTpx in oxidised (purple) and reduced
(blue) states, as well as ypTpxC61S (yellow) indicate that the protein is
monodisperse (dominated by a single, symmetrical peak) with the same
sedimentation coefficient regardless of redox state.
doi:10.1371/journal.pone.0032217.g005
Tpx from Yersinia pseudotuberculosis
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more signal. However, despite this reservation, the preferential
binding of the compound to the ypTpx dimer is consistent with our
modelling data and previous NMR studies that indicated both
subunits contribute to the binding pocket [11].
Conclusion
In summary, we have solved the high-resolution structure of
ypTpx in three forms enabling us to model the binding of
salicylidene acylhydrazide compounds. Binding of the compound,
ME0052, was found (by far-western blotting) to be markedly
stronger to the Tpx dimer compared with the monomer. This is
consistent with the surface area of the modelled binding site
predominantly comprising one subunit yet also including the
dimer interface. The solution structure confirms the oligomeric
state of the protein for both redox states.
Overall, the study provides insights into the binding of the
salicylidene acylhydrazide compounds to ypTpx, aiding our long-
term strategy aiming to understand the mode of action of these
compounds. Further studies characterising the role of the
conformational flexibility observed around the catalytic triad and
dimeric interface in ligand binding may yield additional insights
into the binding mechanisms of these compounds and guide efforts
to design even more effective inhibitors.
Materials and Methods
Protein expression and purification
ypTpx and ypTpxC61S were expressed and purified as described
previously [16], and the N-terminal hexa-histidine tag formed part
of the expressed protein.
Glutamine synthetase assay
The enzymatic activity of ypTpx was demonstrated by a
glutamine synthetase (GS) protection assay [15]. Briefly, 4 ml
(6.7 U) of commercially purchased GS (Sigma) was mixed with
increasing amounts of ypTpx (1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg,
15 mg, 20 mg and 50 mg) and 10 ml inactivation solution (50 mM
DTT, 25 mM FeCl3), in a final volume of 100 ml (made up in
100 mM HEPES pH 7.4). The mix was incubated for 30 min at
room temperature. 2 ml of assay mix (100 mM HEPES, 10 mM
KH2AsO4,2 0 m MN H 2OH, 0.4 mM ADP, 0.5 mM MnCl2,
100 mM glutamine, pH 7.0–7.2) was added to each solution and
the incubation continued at 37uC. After 30 min, 1 ml of stop
solution (5.5% (w/v) FeCl3, 2% (w/v) TCA, 2.1% (v/v)
concentrated HCl) terminated the reaction. Absorbance of the
samples was measured at 540 nm.
Protein crystallisation
Purified proteins were dialysed overnight against 20 mM Tris
pH 7.5, 50 mM NaCl and kept at a concentration of approximately
8m gm l
21 (based on the absorbance at 280 nm, and a calculated
extinction coefficient of 4595 M
21 cm
21), for crystallisation studies
using crystallisation conditions described previously [16].
Diffraction data collection and structure solution
All diffraction data were collected at Diamond Light Source
(Oxfordshire UK), processed with MOSFLM [35] and scaled in
SCALA [36], both parts of the CCP4 suite of programs [37,38], or
d*TREK [39]. The relevant statistics are published elsewhere
Figure 7. Model for salicylidene acylhyrazide ME0052 binding mode to oxidised ypTpx crystal structure. (A) Binding mode for lowest
docked energy ME0052 (atoms represented as CPK orange for carbon, blue for nitrogen and red for bromines) and electrostatic surface for the
protein binding site (Connolly surface, sphere radius=1.4 A ˚). ChemDraw representation for the ME0052 inhibitor is inset. (B) Detailed view of ME0052
binding mode (stick representation). Oxidised ypTpx residues with atom contacts within 3.5 A ˚ of ME0052 inhibitor are shown (cyan). Residues F899
and L359 are contributed by the neighbouring monomer (green). A hydrogen bond (dashed line) is formed between inhibitor and I153 carbonyl. (C)
ME0052 binding mode from (B) with reduced ypTpx (protein backbone magenta ribbon) superposed on oxidised ypTpx; shown are a1 helix and the
R133 side chain of the reduced form partially occluding the binding pocket of oxidised form.
doi:10.1371/journal.pone.0032217.g007
Figure 8. Far-western of purified ypTpx. SDS-PAGE and Coomassie
staining of: lane M, molecular weight ladder; lane 1, ypTpx; lane 2,
ypTpxC61S and (lanes 3 and 4 respectively) far-western of: ypTpx and
ypTpxC61S probed with ME0052-bio. The arrow highlights the presence
of a small amount of dimeric ypTpx on the SDS-PAGE, which can be
contrasted with the far stronger signal from the corresponding band on
the far-western.
doi:10.1371/journal.pone.0032217.g008
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collected and the relevant statistics are found in Table S1.
The structure of E. coli Tpx (PDB 3HVV) was used to solve the
structures of ypTpx by molecular replacement using PHASER [40]
as described previously [16]. Models were refined using RE-
FMAC5 [41] and BUSTER [42], using TLS parameterisation,
and inspected, and manipulated when required, in COOT [43],
where waters were added. Models were validated in COOT and
by the MolProbity server [44]. PDB files were superimposed using
LSQMAN [45].
Analytical ultracentrifugation
AUC was carried out in a Beckman Coulter (Palo Alto, CA)
Optima XL-I analytical ultracentrifuge. Sedimentation velocity (SV)
experiments were performed at 4uC at a rotor speed of 49 k rpm.
360 mlo fypTpxor ypTpxC61S in20 mM TrispH 7.5, 50 mM NaCl,
at four different concentrations between 0.2 and 20 mg ml
21,w e r e
loaded into double sector centrepieces. To impose oxidising or
reducing conditions, 10 mM H2O2or 5 mM DTT, respectively, were
added to the samples. Data were acquired with interference optics;
scans were taken every 7 minutes. Data were analysed using SEDFIT
[24]. The partial specific volume of ypTpx (0.7407 g ml
21/
0.7138 g ml
21) and the buffer density (1.00264 g ml
21/
1.00100 g ml
21) and viscosity (0.015835 P/0.010126 P) at 4uCa n d
20uC respectively, were calculated using the program SEDNTERP
[46]. Sedimentation equilibrium (SE) experiments were performed at
4uC and at rotor speeds of 18 and 24 k rpm. Samples of 80 mlw e r e
loaded under the same conditions as for the SV experiments. Scans
were taken every 3 h until analysis of the scans with WinMATCH
(Jeffrey Lary, University of Connecticut, Storrs, CT, USA) indicated
that equilibrium had been reached. SE data were analysed with
SEDPHAT [25].
Small angle X-ray scattering (SAXS)
SAXS data were collected on the EMBL 633 beamline at the
DORIS storage ring of the DESY (Deutsches Elektronen Synchro-
tron) synchrotron (Hamburg, Germany). X-rays were scattered from
samples of varying concentrations of ypTpx or ypTpxC61S in 20 mM
Tris pH 7.5, 100 mM NaCl. Experiments were carried out at 4uC.
Data were processed using the program PRIMUS [47]. The distance
distribution function and maximum particle dimension (Dmax)w e r e
determined using the program GNOM [27] (Part of ATSAS 2.4
program suite, EMBL Hamburg). Ab initio modelling of ypTpx was
carried out using the program DAMMIN [28]. Twenty DAMMIN
models were generated with an imposed 2-fold (P2) symmetry and
were merged and averaged using the DAMAVER program suite
[48]. The averaged DAMMIN model was superimposed onto the
ypTpx dimer crystal structure using SUPCOMB [49]. Theoretical
scattering curves of the ypTpx monomer and dimer were generated
from the crystal structure coordinates using CRYSOL [50].
Crystal structures were modelled against the solution structure
data by rigid body fitting, using BUNCH [29]. In order to ensure
maintenance of the correct dimer interface in the reconstruction,
distance restraints between interacting interface residues were
imposed, namely a maximum distance of 7 A ˚ between D57 and
R93, and 4 A ˚ between R110 and G125 (based on data from the
high-resolution structure).
Modelling of binding between Tpx and anti-virulence
compounds
All modeling was performed using Molecular Operating
Environment (MOE) (Chemical Computing Group Inc., Mon-
treal, Canada) software. Modeled ME0052 and ME0055 were
subjected to conformational searches for their lowest energy
conformations as docking input. The structures of oxidised and
reduced ypTpx were subjected to energy minimisation with the
MMFF94 force field and the GBSA solvation model prior to
docking. MOE Dock (MOE 2010 version 2010.10) was used in the
alpha triangle mode; the 25 best poses retained for each
compound based on the Affinity dG MOE dock score were
further ranked after energy minimisation.
Figures were made using PyMOL (www.pymol.org), ALINE
[51], and MOE. All crystal structures have been deposited with
the Protein Data Bank (codes presented in Table 1).
Far-western blotting
Samples of ypTpx and ypTpxC61S (100 mM) were heated for
10 min at 95uC with LDS loading buffer (NU-PAGE, Invitrogen)
and run in MES buffer (NU-PAGE, Invitrogen) on a 4–12% Bis-
Tris Novex gel (Invitrogen). The samples were blotted onto a
nitrocelluose membrane and the far-western blot was carried out
as described previously [11,52]. Briefly, the blot was incubated for
4 h at RT in 5% skimmed milk and was probed with 2 mM
ME0052-bio in PBS-Tween for 16 h at 4uC; biotin was detected
using HRP-conjugated StreptAvidin (Invitrogen). Band intensities
were quantified using ImageJ software (Rasband, http://imagej.
nih.gov/ij/, 1997–2011).
Supporting Information
Figure S1 The structure of ypTpxC61S superposed onto
that for ypTpx in the reduced state with an r.m.s.d. of
0.7 A ˚ indicating that the overall fold of the proteins is
highly conserved.
(TIF)
Figure S2 (A) Model for salicylidene acylhydrazide ME0052
(CPK representation) binding to oxidised ypTpx in lowest energy
docked conformation (backbone ribbon representation, Connolly
surface of sphere radius 1.4 A ˚). Each subunit of the homodimer is
coloured differently (cyan and green ribbon). Spheres on the
protein ribbon represent amide groups with largest (blue) and
moderate (yellow) chemical shift perturbation as judged by NMR
HSQC when ME0052 binds [31]. *Amide sphere for L127 (blue).
(B) Alternate binding mode for ME0052 (CPK) to oxidised ypTpx
(cyan ribbon) with reduced ypTpx backbone superposed (magenta
ribbon). The arrow points to the region of significant backbone
and a1 conformational change between oxidised and reduced
states.
(TIF)
Table S1 Data collection statistics for the oxidized ypTpx
obtained in this study. Values in brackets denote highest resolution
shell.
(DOCX)
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